TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T09538	Alkaline phosphatase tissue-nonspecific	D0R1CR	L-Phenylalanine	Approved	6140	C9H11NO2	165.19	C1=CC=C(C=C1)C[C@@H](C(=O)O)N	IC50 = 100100 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	D0DF2M	PMID28870136-Compound-48	Patented	2153	C7H8N4O2	180.16	CN1C2=C(C(=O)N(C1=O)C)NC=N2	Ki = 82000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B0BRN4	N-(1,3-Benzodioxol-5-ylmethyl)-2-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]acetamide	Investigative	50919371	C17H15N3O7S	405.4	C1OC2=C(O1)C=C(C=C2)CNC(=O)CNS(=O)(=O)C3=CC4=C(C=C3)NC(=O)O4	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B0JKS9	N-[(2-Methoxyphenyl)methyl]-4-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]butanamide	Investigative	53245601	C19H21N3O6S	419.5	COC1=CC=CC=C1CNC(=O)CCCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B0LG6R	1-(3,4-Dihydroxyphenyl)-2-(5,6-dimethyl-1-benzimidazolyl)ethanone;hydrochloride	Investigative	25067490	C17H16N2O3	296.32	CC1=CC2=C(C=C1C)N(C=N2)CC(=O)C3=CC(=C(C=C3)O)O	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B14HKR	3-[(2-Oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]-N-[[3-(trifluoromethyl)phenyl]methyl]propanamide	Investigative	53301954	C18H16F3N3O5S	443.4	C1=CC(=CC(=C1)C(F)(F)F)CNC(=O)CCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B2V1GX	N-(4-Cyanophenyl)-2-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]acetamide	Investigative	50919372	C16H12N4O5S	372.4	C1=CC(=CC=C1C#N)NC(=O)CNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 = 81000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B34LMG	N~1~-Benzyl-N~3~-[(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)sulfonyl]-beta-alaninamide	Investigative	24790973	C17H17N3O5S	375.4	C1=CC=C(C=C1)CNC(=O)CCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B3JZ4Y	N-[(4-Methoxyphenyl)methyl]-2-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]acetamide	Investigative	50919379	C17H17N3O6S	391.4	COC1=CC=C(C=C1)CNC(=O)CNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B47DNR	N-[(3-Fluorophenyl)methyl]-4-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]butanamide	Investigative	53245545	C18H18FN3O5S	407.4	C1=CC(=CC(=C1)F)CNC(=O)CCCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B5GEV6	N-(2-Chlorophenyl)-4-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]butanamide	Investigative	76314235	C17H16ClN3O5S	409.8	C1=CC=C(C(=C1)NC(=O)CCCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)Cl	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B5YX0D	Chembl4286917	Investigative	145991559	C13H5F6N3O2S	381.25	C1=CC(=CC=C1C2=NN3C(=O)C=C(N=C3S2)C(F)(F)F)OC(F)(F)F	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B6N5CW	1-(4-Cyanophenyl)-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonyl]urea	Investigative	76328688	C15H10N4O5S	358.3	C1=CC(=CC=C1C#N)NC(=O)NS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B6VUC0	3-[(2-Oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]-N-[[4-(trifluoromethyl)phenyl]methyl]propanamide	Investigative	53301975	C18H16F3N3O5S	443.4	C1=CC(=CC=C1CNC(=O)CCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)C(F)(F)F	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B70JAQ	N-[2-(4-Hydroxyphenyl)ethyl]-4-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]butanamide	Investigative	53245532	C19H21N3O6S	419.5	C1=CC(=CC=C1CCNC(=O)CCCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)O	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B76CPU	N-(3-Cyanophenyl)-2-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]acetamide	Investigative	50919364	C16H12N4O5S	372.4	C1=CC(=CC(=C1)NC(=O)CNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)C#N	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B78BGI	N-[2-(1,3-Benzodioxol-5-yl)ethyl]-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]propanamide	Investigative	51035363	C19H19N3O7S	433.4	C1OC2=C(O1)C=C(C=C2)CCNC(=O)CCNS(=O)(=O)C3=CC4=C(C=C3)NC(=O)O4	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B7FL8B	N-[(4-Methylphenyl)methyl]-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]propanamide	Investigative	53245529	C18H19N3O5S	389.4	CC1=CC=C(C=C1)CNC(=O)CCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B7VT9C	N-[(3-Chlorophenyl)methyl]-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]propanamide	Investigative	53301950	C17H16ClN3O5S	409.8	C1=CC(=CC(=C1)Cl)CNC(=O)CCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B7YDH5	N-[(3,4-Dihydroxyphenyl)methyl]-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]propanamide	Investigative	53301952	C17H17N3O7S	407.4	C1=CC(=C(C=C1CNC(=O)CCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)O)O	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B8AM0R	N,N-Dimethyl-3-(3-oxo-1,2-benzothiazol-2-yl)benzamide	Investigative	16749996	C16H14N2O2S	298.4	CN(C)C(=O)C1=CC(=CC=C1)N2C(=O)C3=CC=CC=C3S2	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B8J1GB	N-[(2,4-Dimethoxyphenyl)methyl]-2-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]acetamide	Investigative	50919368	C18H19N3O7S	421.4	COC1=CC(=C(C=C1)CNC(=O)CNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)OC	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B8WUS7	1-(3,4-Dihydroxyphenyl)-2-(2-ethyl-1-imidazolyl)ethanone	Investigative	25067484	C13H14N2O3	246.26	CCC1=NC=CN1CC(=O)C2=CC(=C(C=C2)O)O	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B90BOK	1-[(2,4-Dimethoxyphenyl)methyl]-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonyl]urea	Investigative	76310601	C17H17N3O7S	407.4	COC1=CC(=C(C=C1)CNC(=O)NS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)OC	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B95YTU	N~1~-(1,3-Benzodioxol-5-ylmethyl)-N~3~-[(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)sulfonyl]-beta-alaninamide	Investigative	46341316	C18H17N3O7S	419.4	C1OC2=C(O1)C=C(C=C2)CNC(=O)CCNS(=O)(=O)C3=CC4=C(C=C3)NC(=O)O4	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B9A0OV	1-[2-(1,3-Benzodioxol-5-yl)ethyl]-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonyl]urea	Investigative	76328686	C17H15N3O7S	405.4	C1OC2=C(O1)C=C(C=C2)CCNC(=O)NS(=O)(=O)C3=CC4=C(C=C3)NC(=O)O4	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B9FWZ0	N-(1,3-Benzodioxol-5-yl)-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]propanamide	Investigative	46341321	C17H15N3O7S	405.4	C1OC2=C(O1)C=C(C=C2)NC(=O)CCNS(=O)(=O)C3=CC4=C(C=C3)NC(=O)O4	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B9JWH4	N-[(3-Fluorophenyl)methyl]-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]propanamide	Investigative	53301967	C17H16FN3O5S	393.4	C1=CC(=CC(=C1)F)CNC(=O)CCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B9P0LE	1-(2,5-Dimethylphenyl)-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonyl]urea	Investigative	76332363	C16H15N3O5S	361.4	CC1=CC(=C(C=C1)C)NC(=O)NS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	B9Z3NQ	Levamisole hydrochloride	Investigative	27944	C11H13ClN2S	240.75	C1CSC2=N[C@H](CN21)C3=CC=CC=C3.Cl	Ki = 93000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BBG4Q9	1-[(4-Methoxyphenyl)methyl]-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonyl]urea	Investigative	76317810	C16H15N3O6S	377.4	COC1=CC=C(C=C1)CNC(=O)NS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BD10OE	Chembl4289495	Investigative	145986829	C12H5F4N3OS	315.25	C1=CC=C(C(=C1)C2=NN3C(=O)C=C(N=C3S2)C(F)(F)F)F	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BD15CR	N-[(4-Chlorophenyl)methyl]-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]propanamide	Investigative	53245562	C17H16ClN3O5S	409.8	C1=CC(=CC=C1CNC(=O)CCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)Cl	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BD8MH1	N-(2,5-Dimethylphenyl)-3-[(2-keto-3H-1,3-benzoxazol-6-yl)sulfonylamino]propionamide	Investigative	24790980	C18H19N3O5S	389.4	CC1=CC(=C(C=C1)C)NC(=O)CCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BDTC90	N~1~-(3,4-Dimethylphenyl)-N~3~-[(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)sulfonyl]-beta-alaninamide	Investigative	24790992	C18H19N3O5S	389.4	CC1=C(C=C(C=C1)NC(=O)CCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)C	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BEP8U7	3-[(2-Keto-3H-1,3-benzoxazol-6-yl)sulfonylamino]-N-o-anisyl-propionamide	Investigative	24790972	C18H19N3O6S	405.4	COC1=CC=CC=C1CNC(=O)CCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BFH56R	N-[3-(1,3-Benzodioxol-5-yl)propyl]-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]propanamide	Investigative	76335991	C20H21N3O7S	447.5	C1OC2=C(O1)C=C(C=C2)CCCNC(=O)CCNS(=O)(=O)C3=CC4=C(C=C3)NC(=O)O4	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BFJ2E1	N-[2-(4-Methoxyphenyl)ethyl]-4-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]butanamide	Investigative	53245527	C20H23N3O6S	433.5	COC1=CC=C(C=C1)CCNC(=O)CCCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BG45HJ	N-[(3-Cyanophenyl)methyl]-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]propanamide	Investigative	51035366	C18H16N4O5S	400.4	C1=CC(=CC(=C1)C#N)CNC(=O)CCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BG5H7S	Chembl4289643	Investigative	145989741	C14H10F3N3OS	325.31	CCC1=CC=C(C=C1)C2=NN3C(=O)C=C(N=C3S2)C(F)(F)F	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BG7UM6	1-(3,4-Dihydroxyphenyl)-2-(4-methyl-1-pyrazolyl)ethanone	Investigative	25199538	C12H12N2O3	232.23	CC1=CN(N=C1)CC(=O)C2=CC(=C(C=C2)O)O	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BH4P8X	1-(3,4-Dimethoxyphenyl)-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonyl]urea	Investigative	76310602	C16H15N3O7S	393.4	COC1=C(C=C(C=C1)NC(=O)NS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)OC	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BHBK75	N-[2-(3,4-Dimethoxyphenyl)ethyl]-4-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]butanamide	Investigative	53245567	C21H25N3O7S	463.5	COC1=C(C=C(C=C1)CCNC(=O)CCCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)OC	IC50 = 96000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BHJ78M	N-[(4-Hydroxyphenyl)methyl]-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]propanamide	Investigative	76328685	C17H17N3O6S	391.4	C1=CC(=CC=C1CNC(=O)CCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)O	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BHQX93	1-(3,4-Dihydroxyphenyl)-2-(2-phenyl-1-imidazolyl)ethanone;hydrochloride	Investigative	25067482	C17H14N2O3	294.3	C1=CC=C(C=C1)C2=NC=CN2CC(=O)C3=CC(=C(C=C3)O)O	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BI42XC	2-(1H-Benzimidazol-2-ylamino)-1-(3,4-dihydroxyphenyl)ethanone;hydrochloride	Investigative	25067486	C15H13N3O3	283.28	C1=CC=C2C(=C1)NC(=N2)NCC(=O)C3=CC(=C(C=C3)O)O	IC50 = 93800 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BJ2KO0	N-[(2,4-Dimethoxyphenyl)methyl]-4-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]butanamide	Investigative	53245533	C20H23N3O7S	449.5	COC1=CC(=C(C=C1)CNC(=O)CCCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)OC	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BKX36C	N-(2,5-Dimethylphenyl)-3-[(3-methyl-2-oxo-1,3-benzoxazol-6-yl)sulfonylamino]propanamide	Investigative	76317808	C19H21N3O5S	403.5	CC1=CC(=C(C=C1)C)NC(=O)CCNS(=O)(=O)C2=CC3=C(C=C2)N(C(=O)O3)C	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BL76YN	Isoproterenone	Investigative	8465	C11H15NO3	209.24	CC(C)NCC(=O)C1=CC(=C(C=C1)O)O	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BM3KU0	N-(2,4-Dimethoxyphenyl)-4-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]butanamide	Investigative	53245566	C19H21N3O7S	435.5	COC1=CC(=C(C=C1)NC(=O)CCCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)OC	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BQD36H	N-(3,4-Dimethoxyphenyl)-4-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]butanamide	Investigative	53384787	C19H21N3O7S	435.5	COC1=C(C=C(C=C1)NC(=O)CCCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)OC	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BQN6U8	N-(1,3-Benzodioxol-5-ylmethyl)-4-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]butanamide	Investigative	53245605	C19H19N3O7S	433.4	C1OC2=C(O1)C=C(C=C2)CNC(=O)CCCNS(=O)(=O)C3=CC4=C(C=C3)NC(=O)O4	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BR2KJ8	N-[(2-Methylphenyl)methyl]-4-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]butanamide	Investigative	53245607	C19H21N3O5S	403.5	CC1=CC=CC=C1CNC(=O)CCCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BR8AL4	N-[(2-Chlorophenyl)methyl]-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]propanamide	Investigative	53301944	C17H16ClN3O5S	409.8	C1=CC=C(C(=C1)CNC(=O)CCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)Cl	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BS0YW4	N-[(3-Methoxyphenyl)methyl]-2-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]acetamide	Investigative	50919378	C17H17N3O6S	391.4	COC1=CC=CC(=C1)CNC(=O)CNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 = 74000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BS48MW	1-(3,4-Dihydroxyphenyl)-2-(1,2,4-triazol-4-yl)ethanone	Investigative	25067488	C10H9N3O3	219.2	C1=CC(=C(C=C1C(=O)CN2C=NN=C2)O)O	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BSWG43	1-(3,4-Dihydroxyphenyl)-2-(2-methyl-1-imidazolyl)ethanone	Investigative	25067492	C12H12N2O3	232.23	CC1=NC=CN1CC(=O)C2=CC(=C(C=C2)O)O	IC50 = 78300 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BTYV61	N-[2-(1,3-Benzodioxol-5-yl)ethyl]-2-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]acetamide	Investigative	50919375	C18H17N3O7S	419.4	C1OC2=C(O1)C=C(C=C2)CCNC(=O)CNS(=O)(=O)C3=CC4=C(C=C3)NC(=O)O4	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BU0F5B	1-(3,4-Dihydroxyphenyl)-2-(1-imidazolyl)ethanone	Investigative	52780	C11H10N2O3	218.21	C1=CC(=C(C=C1C(=O)CN2C=CN=C2)O)O	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BUBP09	N-(3-Cyanophenyl)-3-[(2-keto-3H-1,3-benzoxazol-6-yl)sulfonylamino]propionamide	Investigative	24790981	C17H14N4O5S	386.4	C1=CC(=CC(=C1)NC(=O)CCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)C#N	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BUG01H	N-[(4-Fluorophenyl)methyl]-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]propanamide	Investigative	24792834	C17H16FN3O5S	393.4	C1=CC(=CC=C1CNC(=O)CCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)F	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BV0K1X	N-[(4-Methoxyphenyl)methyl]-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]propanamide	Investigative	51035367	C18H19N3O6S	405.4	COC1=CC=C(C=C1)CNC(=O)CCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BV5T0X	3-[(2-Keto-3H-1,3-benzoxazol-6-yl)sulfonylamino]-N-m-anisyl-propionamide	Investigative	24790974	C18H19N3O6S	405.4	COC1=CC=CC(=C1)CNC(=O)CCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BVWU42	1-[(3-Methoxyphenyl)methyl]-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonyl]urea	Investigative	76325122	C16H15N3O6S	377.4	COC1=CC=CC(=C1)CNC(=O)NS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BW0T5N	N-[(3,4-Dimethoxyphenyl)methyl]-4-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]butanamide	Investigative	53245539	C20H23N3O7S	449.5	COC1=C(C=C(C=C1)CNC(=O)CCCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)OC	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BXG1F6	N-(2-Fluorophenyl)-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]propanamide	Investigative	76317809	C16H14FN3O5S	379.4	C1=CC=C(C(=C1)NC(=O)CCNS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)F	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BYZ79F	1-(3-Cyanophenyl)-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonyl]urea	Investigative	76328687	C15H10N4O5S	358.3	C1=CC(=CC(=C1)NC(=O)NS(=O)(=O)C2=CC3=C(C=C2)NC(=O)O3)C#N	IC50 ~ 100000 nM	Poor binder
T09538	Alkaline phosphatase tissue-nonspecific	BZ5NP7	1-(1,3-Benzodioxol-5-yl)-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonyl]urea	Investigative	76314236	C15H11N3O7S	377.3	C1OC2=C(O1)C=C(C=C2)NC(=O)NS(=O)(=O)C3=CC4=C(C=C3)NC(=O)O4	IC50 ~ 100000 nM	Poor binder